BRL Medicine Inc.
PrivateLast Round
Series B
Extension
Nov 25, 2024
Total Funding Raised
$55.32M
Company Overview
BRL Medicine Inc. is a biotechnology company that develops gene-editing and cell-therapy platforms for the treatment of genetic diseases, cancer, and immune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BRL Medicine Inc. Comparables
Compare BRL Medicine Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EdiGene | 87% | |
| Beijing Yimiao Shenzhou Pharmaceutical Technology | 83% | |
| BriSTAR Immunotech | 83% |
BRL Medicine Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Nov 25, 2024 | ||||
| Series B | Nov 14, 2022 | ||||
| Grant | Dec 1, 2021 | ||||
| Series A Extension | Jun 1, 2018 | ||||
| Series A | Jun 1, 2016 |
BRL Medicine Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series A, Series B |
| Shanghai Municipal People's Government | Grant |
| Gopher Asset Management | Series B |
| Tasly Capital | Series B |
| 华润资本 | Series A Extension |
| Shanghai Free Trade Zone Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2025
Monthly visitors increased 74% MoM, reaching 1.7K.
- Nov 30, 2024
Monthly visitors increased 188% MoM, reaching 4.9K.
BRL Medicine Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BRL Medicine Inc.'s valuation, stock price, and market status.
Is BRL Medicine Inc. a public or private company?
BRL Medicine Inc. is a private company.
What is the current stock price of BRL Medicine Inc.?
BRL Medicine Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is BRL Medicine Inc. worth (valuation)?
Valuation information for BRL Medicine Inc. is not publicly available.
Can I buy BRL Medicine Inc. stock?
BRL Medicine Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BRL Medicine Inc.'s last funding round?
BRL Medicine Inc.'s most recent funding round was Series B Extension on November 25, 2024.
Who are the main investors in BRL Medicine Inc.?
Key investors in BRL Medicine Inc. include Shanghai Municipal People's Government, Shanghai Free Trade Zone Fund.
Will BRL Medicine Inc. IPO soon?
No public IPO plans have been announced for BRL Medicine Inc..
How can I track BRL Medicine Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BRL Medicine Inc.'s secondary market activity and sign up for updates.